Billionaires John Paulson and D.E. Shaw Like This Stock

PAULSON & COAccording to 13F filings for the second quarter, D.E. Shaw increased its position in Mylan Inc (NASDAQ:MYL) by 19% between the beginning of April and the end of June to 16.9 million shares. Mylan, which develops and manufactures both generic and branded pharmaceutical products and ingredients, is also a favorite of billionaire John Paulson’s Paulson & Co. Paulson left its position in the company unchanged during the second quarter at 24.5 million shares. Paulson and D.E. Shaw have often increased and decreased their stakes in Mylan over the past several quarters, but at the end of June it was the fifth largest position in Paulson’s portfolio according to the fund’s 13F (see more stock picks from John Paulson and D.E. Shaw). So far this year Mylan is up 7%, underperforming the NASDAQ index, but it has risen an impressive 11% since the end of June.

The most common investment thesis behind Mylan is that as an increasing number of drugs go off-patent in the coming years, Mylan will be able to develop and sell generic equivalents. The vast majority of Mylan’s revenue is generated by generic drugs, though higher sales of its branded auto-injector for treating allergic reactions caused high growth in the branded segment. Overall, revenues increased 7% in the second quarter compared to the same period a year ago; earnings slightly decreased, but thanks to a fall in share count earnings per share were essentially unchanged. In the first half of 2012, Mylan saw a 7% increase in earnings, as revenue grew 9%, as well as the fall in share count. This drove its earnings per share up to 62 cents, compared to 56 cents in the first half of 2011.

Mylan’s second quarter report beat the Street’s earnings expectations, something the company had done in the previous three quarters as well. The beats have been narrow, but should give investors more confidence in the company’s ability to meet sell-side targets in the future. At the moment, analyst consensus is for earnings per share of $2.74 for 2013 and, with half the year in the books, $2.51 for 2012; this implies a 9% EPS growth rate next year, about in line with what it has done so far this year. The trend in patent expiration gives the company avenues to future growth, and Mylan has recently announced a partnership with Pfizer Inc (NYSE:PFE) to produce generic drugs for the Japanese market. The sell-side’s expectations imply a forward P/E of 9, which seems cheap, and going out further the five-year PEG ratio is 0.9.

The two closest peers for Mylan are Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Watson Pharmaceuticals Inc (NYSE:WPI). Both companies, similarly to Mylan, produce both generic and branded drugs. Teva is a monster value stock on a quantitative basis: it trades at 11 times trailing earnings, 7 times forward earnings estimates, and is coming off a 50% bump in earnings compared to the same period in the previous year. At a $35 billion market capitalization, it is also over three times Mylan’s size. Over the longer term, however, the sell-side has its growth coming in just under the smaller company’s and its five-year PEG ratio is 1. We still think it might be better to take the value and a 2.1% dividend yield now rather than trust the Street. Watson has high growth targets, with its earnings per share expected to increase 40% in 2013 compared to 2012; the forward P/E is 10, but this is higher than either of its peers we’ve discussed and depends on what looks to be quite a bit of optimism. Considering future growth prospects all three of these companies seem like good investments in the trend of generic pharmaceuticals. Mylan is certainly a good pick if investors believe that D.E. Shaw ‘s and Paulson’s positions outweigh the narrowly better value in quantitative terms at Teva.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

The 10 Largest Armies in the World: Who Should We Be Afraid Of?

Best Warren Buffett Quotes on Money You Need to Hear

The 10 Highest Suicide Rates by Profession

The 20 Most Underrated Movies of All Time

The 10 Fastest Growing Companies in America

The 10 Biggest Outlet Malls in USA

The 5 Most Popular Rap Songs of All Time

The 10 Countries that Eat the Most Meat

The10 Most Expensive Countries to Fly To

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!